Covid Vaccines Have Paved the Way for Cancer Vaccines
1 min read
Summary
UK oncologist Lennard Lee is currently leading trials of mRNA cancer vaccines, which are being seen as a potential breakthrough in cancer prevention and treatment globally.
Built on the success of mRNA Covid vaccines, whose development was proven during the Covid pandemic, these new vaccines provide the body with instructions to train the immune system to recognize and attack cancer cells.
In the UK, Lee set up the Cancer Vaccine Launch Pad to fast-track cancer vaccine trials, taking advantage of the country’s proven capabilities in vaccine research and manufacture and swift clinical trial processes.
Initial results from this and other trials are expected by the end of this year or early next, and if successful, the first approved mRNA vaccine will be launched in 2026.
Lee is speaking at WIRED Health in London on March 18; register at health.wired.com.
